The Street’s Key Stock Analysts Research Reports

The Street’s Key Stock Analysts Research Reports

$ACD, $AGN, $ADI, $ARCC, $HALO, $ITCI, $LZB, $LOW

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new tradingand investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of the Street’s Key analysts outlook for main issues for Friday, as follows:

ACADIA Pharmaceuticals (NASDAQ:ACAD) analysts started as Overweight and assigned a 25 price target at Cantor Fitz. The stock trades in a 52-wk range of 12.77 – 41.20 and with a prior consensus target price at 31.24.

Allergan PLC (NYSE:AGN) analysts reiterated as Overweight and the price target was raised to 202 from 181 at Morgan Stanley. Wells Fargo reiterated its Outperform rating but lowered its target price to 232 from 240.

Analog Devices. (NASDAQ:ADI) Stifel reiterated it as Buy and raised the price target to 110 from 108, and Raymond James reiterated its Outperform rating and raised its target price to 110 from 105.

Ares Capital Corp. (NASDAQ:ARCC) was started with a Buy rating and assigned a target price of 19 at Citigroup..

Halozyme Therapeutics Inc. (NASDAQ:HALO) was started as Overweight and assigned a 27 price target at Cantor Fitz. Its market cap is $2.5-B, and it hasa 20.38 consensus target price. .

Intra-Cellular Therapies Inc. (NASDAQ:ITCI) analysts started as Overweight and assigned a 32 price target at Cantor Fitz. It has a $1.09-B market cap and a 52-wk trading range of 10.82 – 25.82. The consensus target price is at 30.00

La-Z-Boy Inc. (NYSE:LZB) was downgraded to Sector Weight from Overweight at KeyBanc Capital Markets, a day after shares rose 13% to 37.45 and after hitting a split-adjusted all-time high of 39.15.

Lowe’s Companies Inc. (NYSE:LOW) analyts reiterated as Buy and the price target was raised to 126 from 113 at Merrill Lynch. UBS maintained its Buy rating but raised its target to 120 from 115, KeyBanc Capital Markets maintained its Overweight rating while raising its target to 125 from 115, at Citigroup, Lowe’s was maintained as Neutral,but with a target hike to 112 from$99 and Wells Fargo reiterated its Outperform rating and raised its target to 120 from 110. Shares closed at 107.15 Thursday, the consensus target price was at 115.38.

Have a terrific weekend

The following two tabs change content below.

Paul Ebeling

Paul A. Ebeling, polymath, excels in diverse fields of knowledge. Pattern Recognition Analyst in Equities, Commodities and Foreign Exchange and author of “The Red Roadmaster’s Technical Report” on the US Major Market Indices™, a highly regarded, weekly financial market letter, he is also a philosopher, issuing insights on a wide range of subjects to a following of over 250,000 cohorts. An international audience of opinion makers, business leaders, and global organizations recognizes Ebeling as an expert.

You must be logged in to post comments :  
CONNECT WITH